We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Immunoassay Evaluated for Cardiac Troponin

By LabMedica International staff writers
Posted on 05 Feb 2013
The analytical performance of an immunoenzymometric assay for the cardiac troponin (cTnI) has been appraised and compared with other methods. More...


The test is a two-site immunoenzymometric assay, which uses a combination of two monoclonal antibodies, respectively directed to 41–49 and 87–91 amino acids of the cTnI peptide chain, and the ternary troponin ITC complex as a calibration antigen.

Scientists at the Fondazione Toscana G. Monasterio (Pisa, Italy) evaluated the assay in 452 healthy individuals of which 326 were males and 126 were female. The median age was 45 years with a range between 17 to 76 years. The study participants were recruited from laboratory staff, blood donors, or voluntary subjects, included in screening programs for preventive medicine.

The immunoenzymometric assay for the cTnI evaluated in the study was the Tosoh ST AIA-PACK cTnI 3rd-Generation, and it uses the automated AIA-2000 platform (Tosoh Corporation, Tokyo, Japan). The third-generation AIA-Pack assay for cTnI showed an improved analytical sensitivity and reproducibility, especially at very low cTnI concentrations compared to the previous second-generation AIA-Pack assay. The values of the third-generation assay were a limit of detection (LoD) at 8.7 ng/L and the limit of quantitation (LoQ) at 100 ng/L. The LoD and 10% LoQ values of the second-generation assay reported previously were 38 ng/L and 130 ng/L, respectively.

The third-generation AIA-Pack Tosoh assay for cTnI showed a very close agreement throughout all the working range with the Access AccuTnI Beckman–Coulter method (Beckman Coulter, Inc.; Fullerton, CA, USA). Close concordance was also demonstrated between the cTnI measured by Tosoh methods and those of cTnT measured with ECLIA Roche method (Roche Diagnostics, Mannheim, Germany). The authors concluded that their results imply that the third generation AIA-Pack assay is suitable for the clinical evaluation of patients with cardiac diseases. The study was published in the January 2013 issue of the journal Clinica Chimica Acta.

Related Links:
Fondazione Toscana G. Monasterio
Beckman Coulter Inc.
Roche Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.